Patrick Williams serves as Chief Financial Officer at NeuroPace, Inc., a pioneering neurotechnology company focused on delivering the RNS System, a responsive neurostimulation device for treating drug-resistant epilepsy. In this role, he oversees all financial operations, including strategic planning, investor relations, capital allocation, and compliance, playing a pivotal part in driving the company's growth and commercialization efforts. Williams joined NeuroPace in October 2021, bringing his deep expertise in financial leadership within the medical device sector to support the expansion of life-changing therapies for epilepsy patients. Prior to NeuroPace, Williams held the position of Executive Vice President and CFO at Penumbra, Inc., from 2016 to 2021, where he guided the company through significant scaling, growing annual revenues from approximately $200 million to over $700 million. His tenure included managing post-IPO financial strategies, international expansion, and multiple acquisitions. Earlier in his career, he served as Vice President of Finance at Intuitive Surgical from 2014 to 2016, contributing to operational efficiencies during a period of rapid innovation in robotic-assisted surgery, and held progressive finance roles at Boston Scientific Corporation. Williams' achievements include successfully navigating complex financial landscapes in high-growth medtech environments, optimizing capital structures to fuel R&D and market penetration, and fostering strong stakeholder relationships that have enhanced long-term shareholder value. His strategic acumen has been instrumental in positioning portfolio companies for sustained profitability and innovation leadership.